These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 7543433

  • 21. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Di Filippo S, Erba G, Pagano A, Locatelli F.
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [Abstract] [Full Text] [Related]

  • 22. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA.
    Martinot-Peignoux M, Boyer N, Cazals-Hatem D, Pham BN, Gervais A, Le Breton V, Levy S, Degott C, Valla DC, Marcellin P.
    Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971
    [Abstract] [Full Text] [Related]

  • 23. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels.
    Puoti C, Magrini A, Stati T, Rigato P, Montagnese F, Rossi P, Aldegheri L, Resta S.
    Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976
    [Abstract] [Full Text] [Related]

  • 24. Hepatitis C virus RNA in peripheral blood mononuclear cells: comparing acute and chronic hepatitis C virus infection.
    Chang TT, Young KC, Yang YJ, Lei HY, Wu HL.
    Hepatology; 1996 May; 23(5):977-81. PubMed ID: 8621178
    [Abstract] [Full Text] [Related]

  • 25. Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests.
    Fong TL, Lee SR, Briggs WK, Valinluck B, Govindarajan S, Hoffman A, Jaczko B, Redeker AG.
    J Med Virol; 1996 Jul; 49(3):253-8. PubMed ID: 8818974
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection.
    Hayashi J, Kishihara Y, Yamaji K, Furusyo N, Yamamoto T, Pae Y, Etoh Y, Ikematsu H, Kashiwagi S.
    Hepatology; 1997 Mar; 25(3):697-701. PubMed ID: 9049221
    [Abstract] [Full Text] [Related]

  • 27. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
    Zaghloul H, El-Sherbiny W.
    Immunol Invest; 2010 Jan; 39(3):284-91. PubMed ID: 20380524
    [Abstract] [Full Text] [Related]

  • 28. Detection of serum hepatitis C virus RNA in HCV antibody-seropositive volunteer blood donors.
    McGuinness PH, Bishop GA, Lien A, Wiley B, Parsons C, McCaughan GW.
    Hepatology; 1993 Sep; 18(3):485-90. PubMed ID: 7689526
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of the patients with low levels of anti-HCV positivity].
    Zer Y, Karaoğlan I, Ciçek H, Karağoz ID, Sağlam M.
    Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
    [Abstract] [Full Text] [Related]

  • 30. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N, Hayashi N, Ohkawa K, Hagiwara H, Oshita M, Katayama K, Sasaki Y, Kasahara A, Fusamoto H, Kamada T.
    Hepatology; 1995 Aug; 22(2):402-6. PubMed ID: 7543432
    [Abstract] [Full Text] [Related]

  • 31. Biochemical, virological and histopathological changes in Danish blood donors with antibodies to hepatitis C virus.
    Grønbaek KE, Jensen OJ, Krarup HB, Dietrichson O.
    Dan Med Bull; 1996 Apr; 43(2):186-8. PubMed ID: 8741210
    [Abstract] [Full Text] [Related]

  • 32. Histological changes but not virus eradication reflect biochemical improvement in chronic hepatitis C patients showing a long-term response to interferon alpha therapy.
    Bruno S, Manzin A, Roncalli M, Petroni ML, Rossi S, Pedicino M, Larghi A, Crosignani A, Podda M.
    Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):31-7. PubMed ID: 9265576
    [Abstract] [Full Text] [Related]

  • 33. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH, Xu XY, Tian GS, Yu YY.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 14; 86(6):390-3. PubMed ID: 16677548
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
    Kakumu S, Sato K, Morishita T, Trinh KA, Nguyen HB, Banh VD, Do HC, Nguyen HP, Nguyen VT, Le TT, Yamamoto N, Nakao H, Isomura S.
    J Med Virol; 1998 Apr 14; 54(4):243-8. PubMed ID: 9557289
    [Abstract] [Full Text] [Related]

  • 35. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.
    Bode JC, Alscher DM, Wisser H, Bode C.
    Alcohol Alcohol; 1995 Jan 14; 30(1):97-103. PubMed ID: 7748281
    [Abstract] [Full Text] [Related]

  • 36. Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.
    Negro F, Krawczynski K, Quadri R, Rubbia-Brandt L, Mondelli M, Zarski JP, Hadengue A.
    Hepatology; 1999 Feb 14; 29(2):536-42. PubMed ID: 9918932
    [Abstract] [Full Text] [Related]

  • 37. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.
    Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, Brugnetti B, Civardi E, Salvaneschi L.
    Hepatology; 1995 Feb 14; 21(2):285-90. PubMed ID: 7843695
    [Abstract] [Full Text] [Related]

  • 38. Early detection of de novo hepatitis C infection in patients after liver transplantation by reverse transcriptase polymerase chain reaction.
    Mateo R, Demetris A, Sico E, Frye C, Wang LF, el-Sakhawi Y, Reilly M, Ehrlich GD, Cooper D, Fung J.
    Surgery; 1993 Aug 14; 114(2):442-8. PubMed ID: 7688155
    [Abstract] [Full Text] [Related]

  • 39. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA, Bailly F, Si-Ahmed SN, Chevallier P, Sepetjan M, Colucci G, Trépo C.
    J Med Virol; 1997 May 14; 52(1):105-12. PubMed ID: 9131466
    [Abstract] [Full Text] [Related]

  • 40. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B, Qian C, Riezu-Boj JI, Civeira MP, Prieto J.
    Hepatology; 1993 Nov 14; 18(5):1050-4. PubMed ID: 8225209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.